EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Role of genetic testing in young patients with idiopathic atrioventricular conduction disease

Angelo Auricchio iD, Andrea Demarchi, Tardu Özkartal iD, Daniela Campanale iD, Maria Luce Caputo iD, Marcello di Valentino iD, Andrea Menafoglio, Francois Regoli, Marco Facchini, Alessandro Del Bufalo, Pietro Foglia, Nicola Ferrari und 6 weitere

EP Europace · 2023

DOI: 10.1093/europace/euac196 ↗

Kurz gefasst

Fachartikel in der Zeitschrift EP Europace, 2023. Verfasst von Angelo Auricchio und 17 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Cardiocentro Ticino Institute, Ente Ospedaliero Cantonale, Lugano 6900, Switzerland. Hauptthemen laut MEDLINE: Atrioventricular Block, Pacemaker, Artificial. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Swiss Heart Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

To investigate the role of genetic testing in patients with idiopathic atrioventricular conduction disease requiring pacemaker (PM) implantation before the age of 50 years. Methods and results All consecutive PM implantations in Southern Switzerland between 2010 and 2019 were evaluated. Inclusion criteria were: (i) age at the time of PM implantation: < 50 years; (ii) atrioventricular block (AVB) of unknown aetiology. Study population was investigated by ajmaline challenge and echocardiographic assessment over time. Genetic testing was performed using next-generation sequencing panel, containing 174 genes associated to inherited cardiac diseases, and Sanger sequencing confirmation of suspected variants with clinical implication. Of 2510 patients who underwent PM implantation, 15 (0.6%) were young adults (median age: 44 years, male predominance) presenting with advanced AVB of unknown origin. The average incidence of idiopathic AVB computed over the 2010–2019 time window was 0.7 per 100 000 persons per year (95% CI 0.4–1.2). Most of patients (67%) presented with specific genetic findings (pathogenic variant) or variants of uncertain significance (VUS). A pathogenic variant of PKP2 gene was found in one patient (6.7%) with no overt structural cardiac abnormalities. A VUS of TRPM4, MYBPC3, SCN5A, KCNE1, LMNA, GJA5 genes was found in other nine cases (60%). Of these, three unrelated patients (20%) presented the same heterozygous missense variant c.2531G > A p.(Gly844Asp) in TRPM4 gene. Diagnostic re-assessment over time led to a diagnosis of Brugada syndrome and long-QT syndrome in two patients (13%). No cardiac events occurred during a median follow-up of 72 months.

Conclusion

Idiopathic AVB in adults younger than 50 years is a very rare condition with an incidence of 0.7 per 100 000 persons/year. Systematic investigations, including genetic testing and ajmaline challenge, can lead to the achievement of a specific diagnosis in up to 20% of patients. Heterozygous missense variant c.2531G > A p.(Gly844Asp) in TRPM4 gene was found in an additional 20% of unrelated patients, suggesting possible association of the variant with the disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrioventricular BlockPacemaker, ArtificialYoung AdultHumansMaleAdultMiddle AgedFemaleCardiac Conduction System DiseaseGenetic TestingAjmaline

Stichwörter der Autor:innen

Atrioventricular BlockGeneticsInherited heart diseasePacemakerTRPM4

Substanzen

Ajmaline

Autor:innen und Institutionen

  • Division of Cardiology, Cardiocentro Ticino Institute, Ente Ospedaliero Cantonale, Lugano 6900, Switzerland.
  • Division of Cardiology, Ospedale di Bellinzona, Bellinzona 6500, Switzerland.
  • Division of Cardiology, Ospedale di Locarno, Locarno 6600, Switzerland.
  • Swiss DNAlysis, Cardiogenetics, Düdendorf 8600, Switzerland.
  • Service Clinical Epidemiology and Biometry, Fondazione IRCCS Policlinico San Matteo, Pavia 27100, Italy.

ORCID-Profile: Angelo Auricchio, Tardu Özkartal, Daniela Campanale, Maria Luce Caputo, Marcello di Valentino, Argelia Medeiros-Domingo, Tiziano Moccetti, Giovanni B Pedrazzini, Catherine Klersy, Giulio Conte

Förderung

  • Swiss Heart Foundation

Zitieren

APA

Auricchio, A., Demarchi, A., Özkartal, T., Campanale, D., Caputo, M. L., di Valentino, M., Menafoglio, A., Regoli, F., Facchini, M., Del Bufalo, A., Foglia, P., Ferrari, N., Bomio, F., Medeiros-Domingo, A., Moccetti, T., Pedrazzini, G. B., Klersy, C., & Conte, G. (2023). Role of genetic testing in young patients with idiopathic atrioventricular conduction disease. EP Europace. https://doi.org/10.1093/europace/euac196

Vancouver

Auricchio A, Demarchi A, Özkartal T, Campanale D, Caputo ML, di Valentino M, et al. Role of genetic testing in young patients with idiopathic atrioventricular conduction disease. EP Europace. 2023. doi:10.1093/europace/euac196

BibTeX
@article{Auricchio2023,
  author = {Auricchio, Angelo and Demarchi, Andrea and Özkartal, Tardu and Campanale, Daniela and Caputo, Maria Luce and di Valentino, Marcello and Menafoglio, Andrea and Regoli, Francois and Facchini, Marco and Del Bufalo, Alessandro and Foglia, Pietro and Ferrari, Nicola and Bomio, Fulvio and Medeiros-Domingo, Argelia and Moccetti, Tiziano and Pedrazzini, Giovanni B and Klersy, Catherine and Conte, Giulio},
  title = {Role of genetic testing in young patients with idiopathic atrioventricular conduction disease},
  journal = {EP Europace},
  year = {2023},
  doi = {10.1093/europace/euac196}
}
Kostenlos starten →